SCHEMBL982364

SCHEMBL982364

c1ccc2c(c1)-c1ccccc1C2c1c2ccccc2c(C2c3ccccc3-c3ccccc32)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.46
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
GPR3 P46089 2/20 0.41
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CYP1A2 P05177 2/20 0.34
KDM1A O60341 1/20 0.34
CYP2D6 P10635 1/20 0.34
POLB P06746 1/20 0.34
SLC6A2 P23975 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29490167 0.81 HTR2A (0.48) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL1304934 0.81 HTR2A (0.48) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL18317074 0.80 HTR2A (0.35) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL4022049 0.79 HTR2A (0.46) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL9068624 0.75 KMT2A (0.50) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL6658831 0.75 HTR2A (0.43) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL7162600 0.74 MAPK1 (0.45) HTR2AMEN1KMT2ACYP1A2NPC1
SCHEMBL6675754 0.73 KDM1A (0.53) HTR2AMEN1KMT2ACYP1A2KDM1A
SCHEMBL1667065 0.73 HTR2A (0.41) HTR2AMEN1GAAKMT2AGPR3
SCHEMBL16481156 0.73 KDM1A (0.48) HTR2AGAACA1CA2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106348993-B Bury in oblivion agent and its preparation and application method applied to converting system on T-T annihilation 天津大学 2019-07-19 CN claimed
CN-106348993-A Annihilation agent applied to triplet-triplet annihilation up-conversion system, and preparation and application methods thereof 天津大学 2017-01-25 CN claimed
EP-1786885-B1 ELECTROLUMINESCENT MATERIALS AND DEVICES MERCK PATENT GMBH (DE) 2011-05-18 EP claimed
US-20080113215-A1 Electroluminescent Materials and Devices MERCK PATENT GMBH (DE) 2008-05-15 US claimed
US-20070252108-A1 Electroluminescent Materials and Devices MERCK PATENT GMBH (DE) 2007-11-01 US claimed
EP-2984079-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES POWER OLEDS LTD (GB) 2020-07-01 EP disclosed
US-10439147-B2 Heterocyclic compounds and their use in electro-optical or opto-electronic devices POWER OLEDS LIMITED (GB) 2019-10-08 US disclosed
CN-106348993-B Bury in oblivion agent and its preparation and application method applied to converting system on T-T annihilation 天津大学 2019-07-19 CN disclosed
US-20180323378-A9 HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES POWER OLEDS LIMITED (GB) 2018-11-08 US disclosed
EP-2232611-B1 BARRIER COATED SUBSTRATE AND ELECTRO-OPTICAL DEVICE MERCK PATENT GMBH (DE) 2017-11-01 EP disclosed
CN-106348993-A Annihilation agent applied to triplet-triplet annihilation up-conversion system, and preparation and application methods thereof 天津大学 2017-01-25 CN disclosed
CN-106348993-A Annihilation agent applied to triplet-triplet annihilation up-conversion system, and preparation and application methods thereof 天津大学 2017-01-25 CN disclosed
WO-2008081178-A1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER MERCK PATENT GMBH (DE) 2008-07-10 WO disclosed
WO-2008078114-A1 ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-07-03 WO disclosed
WO-2008078115-A1 PHENANTHROLINE COMPOUNDS AND ELECTROLUMINESCENT DEVICES USING THE SAME MERCK PATENT GMBH (DE) 2008-07-03 WO disclosed
US-20080113215-A1 Electroluminescent Materials and Devices MERCK PATENT GMBH (DE) 2008-05-15 US disclosed
US-20070252108-A1 Electroluminescent Materials and Devices MERCK PATENT GMBH (DE) 2007-11-01 US disclosed
EP-1786885-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES OLED-T LIMITED (GB) 2007-05-23 EP disclosed
WO-2006090098-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES OLED-T LIMITED (GB) 2006-08-31 WO disclosed
WO-2006016176-A1 ELECTROLUMINESCENT MATERIALS AND DEVICES OLED-T LIMITED (GB) 2006-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180323378-A9 HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES NAT1, SLCO2A1, SLCO2B1 HTR2A 301/4885MEN1 2174/4885GAA 4637/4885
US-20070252108-A1 Electroluminescent Materials and Devices AAAS, ANXA1, ANXA2 HTR2A 3492/4885MEN1 983/4885GAA 1466/4885
US-10439147-B2 Heterocyclic compounds and their use in electro-optical or opto-electronic devices NAT1, SLCO2A1, SLCO2B1 HTR2A 301/4885MEN1 2174/4885GAA 4637/4885
US-20080113215-A1 Electroluminescent Materials and Devices AAAS, ACMSD, KCNH1 HTR2A 2668/4885MEN1 318/4885GAA 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.